The antimicrobial resistance alliance recently released its third Progress Report, reflecting on collective achievements from the life sciences industry
Pfizer and Moderna are also working on vaccines that target the Omicron variant
The recommendations have been sent to the Drugs Controller General of India (DCGI) for the final approval
Restasis has been approved for use in the U.S. for nearly 20 years, but until today, there was no approved generic product of this drug
Fiscal support in line with what is available in key innovation hubs such as USA and China will drive the next leg of drug discovery in India
In the April-September 2021 period, the FDI inflows continued to be buoyant at Rs 4,413 crore, growing at the rate of 53 per cent over the same period in 2020-21
Allocation for the healthcare sector has gone up but is still woefully short of expectations. A few leading voices from the hospital and consulting sectors share their perspective on what they expect from Budget 2022
Medtech plays a vital role in the healthcare system and players in this field believe that the budget should address some of their concerns if India has to become a formidable player
Intranasal vaccines are easier to administer in mass immunisation campaigns and help reduce or stop transmission
The vaccines are currently only authorised for emergency use in the country
Subscribe To Our Newsletter & Stay Updated
